Cooley advised Corxel Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for obesity and related cardiometabolic conditions, on its definitive business combination agreement with Amanat Acquisition Corp., a publicly traded special purpose acquisition company.
Cooley Advised Corxel Pharmaceuticals on Business Combination Agreement with Amanat Acquisition Corp